Drawing for Serial No. 79345693

USPTO serial 79345693

Serial No. 79345693

Reviewed by CopyMark Law Group

Reg. 7095580Status 700Registered
Filing date
Status date
Registration date
Jul 4, 2023
Examiner
MARTIN, LIEF ANDREW
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with Serial No. 79345693?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Gregory J. Chinlund

Gregory J. Chinlund Marshall, Gerstein & Borun LLP233 South Wacker Drive, Suite 6300Chicago, IL 60606UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and veterinary preparations for use in the treatment of cancer, autoimmune diseases, and medical conditions arising from transplantation and gene therapy, and for use with transplantation and gene therapy; pharmaceutical preparations, namely, preparations for cleaving human antibodies; pharmaceutical preparations and veterinary preparations, namely, enzyme preparations and sterilizing preparations; sanitary preparations, namely, chemical enzyme preparations and sterilizing preparations; medicines for diagnosing, preventing, and treating cancer and autoimmune diseases for human and veterinary purposes; pharmaceutical preparations for elimination of antibodies for therapeutic purposes in immune related diseases and conditions; enzymes for medical and veterinary purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 31, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 10, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 10, 2023FIMPFINAL DISPOSITION PROCESSED—
Oct 4, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 4, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 4, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 18, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 18, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 29, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 10, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 3, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 2, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 2, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 2, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 18, 2022RFNPREFUSAL PROCESSED BY IB—
Sep 25, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 24, 2022RFRRREFUSAL PROCESSED BY MPU—
Aug 5, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 4, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 3, 2022DOCKASSIGNED TO EXAMINER—
Jul 26, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 22, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 21, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance